The World Federation of Haemophilia (WFH) and European Haemophilia Consortium (EHC) yesterday issued a joint statement on the AstraZeneca vaccine for people with rare bleeding disorders.
The take-home message for us is:
- The benefits of the vaccine continue to outweigh the risks for people who receive it.
- The risks of adverse events is no higher in people with bleeding disorders.